REGN Regeneron Pharmaceuticals

held 9 mo · 3 quarters on record · no longer held REGN across all managers

Position over time

Period	Shares	% of portfolio	Activity	Value
Q3 2020	35,582	0.58%	Reduce 8.1%	$20M
Q2 2020	38,700	0.74%	NEW	$24M
Q3 2017	31,800	0.65%	NEW	$14M

Search